Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
7th Sep 20229:00 amRNSDirector/PDMR Shareholding
31st Aug 20225:00 pmRNSTotal Voting Rights
30th Aug 20224:30 pmRNSDirector/PDMR Shareholding
18th Aug 20225:00 pmRNSDirector/PDMR Shareholding
16th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS2022 Half-Year Results
9th Aug 20224:30 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSPhoenix Group to acquire Sun Life UK
29th Jul 20224:00 pmRNSTotal Voting Rights
27th Jul 20223:45 pmRNSHolding(s) in Company
27th Jul 20223:31 pmRNSHolding(s) in Company
7th Jul 20224:45 pmRNSDirector/PDMR Shareholding
1st Jul 20222:00 pmRNSTotal Voting Rights
30th Jun 20224:30 pmRNSBlock Listing Return
29th Jun 20224:00 pmRNSBoard Changes Announcement
27th Jun 20223:15 pmRNSBlocklisting Application Announcement
9th Jun 20223:30 pmRNSDirector/PDMR Shareholding
31st May 20229:30 amRNSTotal Voting Rights
30th May 202211:00 amRNSBlock Listing Application
25th May 20223:00 pmRNSDirector/PDMR Shareholding
16th May 20224:30 pmRNSDirector/PDMR Shareholding
9th May 20223:00 pmRNSDirector/PDMR Shareholding
9th May 20222:15 pmRNSBoard Changes
5th May 20221:14 pmRNSResult of AGM
29th Apr 20225:00 pmRNSTotal Voting Rights
20th Apr 20226:30 pmRNSDirector/PDMR Shareholding
11th Apr 20226:00 pmRNSDirector/PDMR Shareholding
7th Apr 20224:45 pmRNSDirector/PDMR Shareholding
6th Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSTotal Voting Rights
30th Mar 20222:00 pmRNSDirector/PDMR Shareholding
25th Mar 20225:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:00 pmRNSNotice of AGM
16th Mar 20226:27 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNS2021 Annual Financial Report
9th Mar 202211:30 amRNSDirector/PDMR Shareholding
8th Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20224:30 pmRNSTotal Voting Rights
23rd Feb 20227:00 amRNSBoard Changes
11th Feb 20225:15 pmRNSDirector/PDMR Shareholding
11th Feb 202212:00 pmRNSDirector/PDMR Shareholding
9th Feb 20229:00 amRNSDirector/PDMR Shareholding
7th Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.